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Abstract
Functional data analysis, which handles data arising from curves, surfaces, volumes, mani-
folds and beyond in a variety of scientific fields, is a rapidly developing area in modern statistics
and data science in the recent decades. The effect of a functional variable on an outcome is an
essential theme in functional data analysis, but a majority of related studies are restricted to
correlational effects rather than causal effects. This paper makes the first attempt to study the
causal effect of a functional variable as a treatment in observational studies. Despite the lack
of a probability density function for the functional treatment, the propensity score is properly
defined in terms of a multivariate substitute. Two covariate balancing methods are proposed
to estimate the propensity score, which minimize the correlation between the treatment and
covariates. The appealing performance of the proposed method in both covariate balance and
causal effect estimation is demonstrated by a simulation study. The proposed method is applied
to study the causal effect of body shape on human visceral adipose tissue.
Key Words: Functional principal component analysis; Empirical likelihood; Method of moments;
Inverse probability weighting.
1 Introduction
Functional data, which arise from curves, surfaces, volumes, manifolds and beyond, are in-
creasingly common in a variety of fields due to recent technological innovations in data collection,
data storage and scientific computing. The broad availability of functional datasets and imme-
diate analytic demand have stimulated the rapid development of functional data analysis (FDA)
in the past few decades and enhanced its importance in modern statistics and data science. For
systematic introductions to FDA and select topics, readers may refer to representative monographs
(e.g., Bosq, 2000; Ferraty and Vieu, 2006; Horva´th and Kokoszka, 2012; Hsing and Eubank, 2015;
Kokoszka and Reimherr, 2017; Ramsay and Silverman, 2005; Zhang, 2013).
To study the association between a functional predictor and a scalar response, which is a classic
topic in FDA, functional regression is the most popular class of approaches (see survey papers, e.g.,
by Morris, 2015; Reiss et al., 2017). However, functional regression can only reveal the correlation
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between the response and functional predictor, although the causal relationship between those is of
primary interest in certain scientific studies. Despite its intellectual merit and practical impact, the
research on causal inference in FDA has been inadequate. Among very few existing works, almost
all of them focus on either clinical trials or functional variables as covariates (e.g., Ciarleglio et al.,
2015, 2018; Lindquist, 2012; McKeague and Qian, 2014; Miao et al., 2020; Zhao and Luo, 2019).
In contrast, we consider a functional variable as a treatment in observational studies.
In the literature on causal inference for observational studies, the causal effect estimation
of a binary treatment is a classic topic and has been intensively studied (see reviews, e.g., by
Ding and Li, 2018; Imbens, 2004; Stuart, 2010; Yao et al., 2020). In the past few decades, an in-
creasing number of papers have appeared on multi-level categorical treatments or continuous treat-
ments (e.g., Fong et al., 2018; Hirano and Imbens, 2004; Imai and Van Dyk, 2004; Imbens, 2000;
Kennedy et al., 2017; Li and Li, 2019; Lopez and Gutman, 2017; Robins et al., 2000; Yang et al.,
2016; Zhu et al., 2015). Recently, treatments of more complex forms have gradually received more
attentions, such as multidimensional categorical treatments (e.g., D’Amour, 2019; Wang and Blei,
2019) and matrix treatments (e.g., Yu et al., 2020) among others. To the best of our knowledge,
this paper is the first to handle functional treatments in observational data.
Figure 1: Body circumference over the trunk and two legs of a person sampled at 128 equidistant levels from
neck to ankle. The shadeless portion represents the adnominal region.
The practical motivation of this paper is the assessment of human visceral adipose tissue (VAT)
using body shape descriptors (e.g., Samouda et al., 2013; Sun et al., 2017; Wang et al., 2019). VAT
is a type of body fat that is stored within the abdominal cavity and located near several vital
organs such as liver, stomach, and intestines. Accurate quantitative assessment of VAT is clinically
essential since it is known to be associated with the risk for several medial problems, including heart
disease, Alzheimer’s disease, type 2 diabetes, stroke, insulin resistance and high cholesterol among
others (e.g., Despre´s, 2007; Jung et al., 2016). Commonly used medical equipments which can
provide accurate VAT measurements include dualenergy X-ray absorptiometry (DXA), computed
tomography (CT) and magnetic resonance imaging. However, using them is always expensive and
reliant on professional operations, and some equipments, e.g., DXA and CT, may expose patients
to ionizing radiation (e.g., Yeh et al., 2009). Due to the prevalence of commodity optical body
scan systems, body shape provides a safe and affordable alternative to assessing VAT volume
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(e.g., Ng et al., 2016). Figure 1 provides an illustration of body circumference from neck and
ankle, a body shape descriptor extracted from 3D body geometry captured by a commodity level
optical body scanner (Lu et al., 2019; Wang et al., 2019). Apparently body circumference may be
regarded as a functional variable of which input is each level between neck and ankle. Following
the framework by Neyman (1923) and Rubin (1974), body shape may be regarded as a treatment
since people are able to physically intervene it, or parts of it, e.g., via dietary management and
exercise, but researchers have so far only focused on its correlation with VAT rather than their
causal relationship. In this paper we will fill this void and apply our proposed method to study the
causal effect of body shape on VAT.
The main contribution of this paper is twofold. First, the propensity score for functional treat-
ments is properly defined, termed “functional propensity score”, to balance covariates. When a
treatment is binary, multi-level categorical or continuous, the propensity score (Rosenbaum and Rubin,
1983) or generalized propensity score (Hirano and Imbens, 2004; Imai and Van Dyk, 2004; Imbens,
2000) has been commonly used to balance covariates, which is defined in terms of the conditional
mass/density function of the treatment given covariates. However, this way of defining propensity
scores is inapplicable to functional treatments since the density function for a functional variable
generally does not exist (Delaigle and Hall, 2010). To circumvent this problem, we propose to
substitute the functional treatment by its top functional principal component (FPC) scores, a
multivariate variable, and define the functional propensity score by the conditional density func-
tion of the FPC scores given covariates. Second, we propose two covariate balancing methods
to estimate the functional propensity score. Traditionally the propensity score is estimated by
a parametric model together with maximum likelihood, but it is well known that this approach
may suffer from model misspecification substantially (e.g., Kang and Schafer, 2007). To alleviate
this drawback, covariate balancing methods with the aim to mimic randomization have been very
popular recently (e.g., Chan et al., 2016; Hainmueller, 2012; Imai and Ratkovic, 2014; Li et al.,
2018; Qin and Zhang, 2007; Wong and Chan, 2018; Yiu and Su, 2018; Zhao, 2019; Zubizarreta,
2015). Following the same idea, we seek functional propensity score estimates which can minimize
the correlation between the FPC scores and covariates. Our methods generalize the parametric
and nonparametric covariate balancing methods by Fong et al. (2018) to estimate the generalized
propensity score for continuous treatments, which can improve likelihood-based parametric estima-
tion and avoid parametric misspecification respectively. With a functional propensity score esti-
mate, we fit the outcome model by inverse probability weighting (Hirano et al., 2003; Robins et al.,
2000; Rosenbaum, 1987), which is closely related to the covariate balancing measure.
The rest of the paper proceeds as follows. Section 2 provides the definition of the functional
propensity score. In Section 3, two covariate balancing methods are proposed to estimate the func-
tional propensity score, and the causal effect estimation by functional propensity score weighting
is also introduced. Section 4 presents a simulation study to evaluate the performances of the two
proposed methods with respect to covariate balancing and causal effect estimation accuracy. In
Section 5, the proposed methods are applied to study the causal effect of body circumference on
VAT. Section 6 concludes the paper.
2 Functional Propensity Score
Let Y be a continuous outcome, the treatment X be a smooth, e.g., twice-differentiable, random
function defined on a compact domain T which is square-integrable, i.e., E{∫T X2(t) dt} <∞, and
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C be a p−dimensional multivariate covariate with E(C⊤C) < ∞. Without loss of generality we
assume T = [0, 1], E{X(t)} = 0, t ∈ [0, 1] and E(C) = 0. Suppose that we observe n samples
{(Yi,Xi,Ci) : i = 1, . . . , n} in practice, which are independently and identically distributed (i.i.d.)
copies of (Y,X,C). For simplicity the trajectories of all {Xi : i = 1, . . . , n} are assumed fully
observable and uncontaminated by noise. We aim to estimate E{Y (x)} in terms of {(Yi,Xi,Ci) :
i = 1, . . . , n}, where x ∈ L2 = {f : ∫ 10 f2(t) dt < ∞} is any functional value the treatment X can
take.
Following the classical causal inference literature, we assume strong ignorablity.
Assumption 1 (Strong Ignorability). Let Y (x) be the potential outcome given the treatment value
X = x. Assume X ⊥ Y (x) | C for all x ∈ L2, where “⊥” represents independence.
The propensity score or generalized propensity score for a categorical or continuous treat-
ment is defined in terms of the conditional probability mass/density function of the treatment
given covariates. However, this way of defining the propensity score is inapplicable for functional
treatments since the probability density function for a functional variable generally does not exist
(Delaigle and Hall, 2010). Therefore we propose to define the propensity score in terms of functional
principal component (FPC) scores of the functional treatment.
Explicitly, the Karhunen-Loe`ve theorem allows for the representation X(t) =
∑∞
k=1Akφk(t),
t ∈ [0, 1], where φk, k ≥ 1 are eigenfunctions corresponding to the eigenvalues λ1 ≥ λ2 ≥ · · · > 0 of
the covariance function Cov{X(s),X(t)}. The FPC scores Ak =
∫ 1
0 X(t)φk(t), k ≥ 1 are mutually
uncorrelated with zero means and Var(Ak) = λk, k ≥ 1. Typically X can be well approximated by
the first L summands, i.e., X(t) ≈ ∑Lk=1Akφk(t), where L is often determined such that the top
Ak, k = 1, . . . , L cumulatively account for a large proportion of variation of X, e.g., 95% or 99%.
Since the majority of Xi’s information can be captured by A = (A1, . . . , AL)
⊤, we may use A, a
multivariate substitute for X, to define the propensity score. Apparently if X is of finite rank L,
then A can fully capture the information on X.
We next define the propensity score for functional treatments in terms of A, an L-dimensional
substitute of X.
Definition 1 (Functional Propensity Score). Let r be the conditional probability density func-
tion of A given C, i.e., r(a, c) = fA|C(a | c). The rank-L functional propensity score (FPS) is
defined by ei = r(Ai,Ci), , i = 1, . . . , n. The corresponding rank-L FPS weight is defined by
wi = fA(Ai)/ei, i = 1, . . . , n, where fA(·) is the marginal density of A.
In practice, one may standardize data before the analysis. Since A1, . . . , AL are mutually un-
correlated with Var(Ak) = λk, k = 1, . . . , L, the standardized A is A
∗ = (A∗1, . . . , A
∗
L)
⊤ where
A∗k = λ
−1/2
k Ak, k = 1, . . . , L. Let C
∗ = Γ
−1/2
C
C be the standardized C where ΓC = E(CC
⊤).
Similarly for the ith subject, denote C∗i = Γ
−1/2
C
Ci and A
∗
i = (A
∗
i1, . . . , A
∗
iL)
⊤ where Aik =
λ
−1/2
k
∫ 1
0 Xi(t)φk(t), k = 1, . . . , L. Then the functional propensity score can be alternatively de-
fined in terms of A∗ and C∗.
Definition 2 (Standardized Functional Propensity Score). Let r∗ be the conditional probability
density function of A∗ given C∗, i.e., r∗(a, c) = fA∗|C∗(a | c). The rank-L standardized functional
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propensity score (SFPS) is defined by e∗i = r
∗(A∗i ,C
∗
i ), , i = 1, . . . , n. The corresponding rank-L
SFPS weight is w∗i = fA∗(A
∗
i )/e
∗
i , i = 1, . . . , n, where fA∗(·) is the marginal density of A∗.
We further assume positivity for both FPS and SFPS.
Assumption 2 (Positivity). For r and r∗ in Definitions 1 and 2 respectively, assume that r(a,Ci), r
∗(a,C∗i ) >
0 for all a ∈ RL.
For simplicity, hereafter we will only use SFPS to remove or mitigate the imbalance between
the functional treatment and covariates.
Remark 1.
1. Note that φk, λk, Aik, k ≥ 1, i = 1, . . . , n and ΓC above are population quantities. In practice we
can only obtain their sample counterparts, but for brevity we abuse these notations to denote either
the population or sample versions depending on their corresponding contexts.
2. In practice functional data are always discretely measured and may be contaminated by noise.
For densely measured functional data, one may pre-smooth each function to accurately recover its
trajectory (e.g., Zhang and Chen, 2007) and the FPC scores accordingly.
3. To achieve a satisfactory balance between the functional treatment and covariates, the rank L
of both FPS and SFPS is supposed to be sufficiently large such that a majority of the variation of
the functional treatment is represented by its top FPC scores. The most commonly used method
for selecting L is via the percentage of variance explained by the top FPC scores, which is typically
set as 95% or 99%. Note that the selection of L is constrained by the sample size and number of
covariates, which will be addressed in Remark 2.
3 Methodology
In this section we propose two covariate balancing methods to estimate the rank-L FPS weights
and the corresponding causal effect estimation by FPS weighting.
3.1 SFPS Estimation
Without loss of generality we focus on A∗i and C
∗
i , i = 1, . . . , n after standardization. To
balance covariates, we seek weights to minimize the weighted correlation between A∗i and C
∗
i . By
easy calculations we can obtain
Ew∗iA
∗
i (C
∗
i )
⊤ = 0, i = 1, . . . , n. (1)
Thus the rank-L SFPS weight w∗i = fA∗(A
∗
i )/fA∗|C∗(A
∗
i | C∗i ), i = 1, . . . , n is a minimizer.
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Motivated by Fong et al. (2018) who focused on continuous treatments, we consider a paramet-
ric and a nonparametric method to estimate rank-L SFPS weights with the covariate balancing
condition (1) taken into account.
Parametric SFPS Estimation. To estimate w∗i = fA∗(A
∗
i )/fA∗|C∗(A
∗
i | C∗i ), i = 1, . . . , n, we
assume parametric structures on fA∗ and fA∗|C∗ and estimate involved unknown parameters. First
we assume that A∗ is jointly normal. Then since the components of A∗, which are standardized
FPC scores, are mutually uncorrelated, fA∗ is known as
fA∗(A
∗
i ) = (2π)
−L/2 exp
{
−1
2
(A∗i )
⊤ (A∗i )
}
.
We further assume that A∗ given C∗ is also jointly normal. Then there exist unknown matrices β
and Σ such that
fA∗|C∗(A
∗
i | C∗i ) = (2π)−L/2 det (Σ)−1/2 exp
{
−1
2
(
A∗i − β⊤C∗i
)⊤
Σ−1
(
A∗i − β⊤C∗i
)}
,
so w∗i = det (Σ)
1/2 exp
{
1
2
(
A∗i − β⊤C∗i
)⊤
Σ−1
(
A∗i − β⊤C∗i
)
− 1
2
(A∗i )
⊤ (A∗i )
}
. (2)
Based on the fact E
(
A∗i − β⊤C∗i
) (
A∗i − β⊤C∗i
)⊤
= Σ together with (1), we solve the following
method-of-moments equations to estimate the unknown parameters β and Σ:
n
−1
∑n
i=1
(
A∗i − β⊤C∗i
) (
A∗i − β⊤C∗i
)⊤
= Σ;
n−1
∑n
i=1 det (Σ)
1/2 exp
{
1
2
(
A∗i − β⊤C∗i
)⊤
Σ−1
(
A∗i − β⊤C∗i
)− 12 (A∗i )⊤ (A∗i )}A∗i (C∗i )⊤ = 0.
With the estimates of β and Σ, w∗i , i = 1, . . . , n can be estimated following (2).
Nonparametric SFPS Estimation. To avoid possible parametric misspecification for the SFPS,
one may adopt the empirical likelihood method (Owen, 2001) instead where no parametric assump-
tion is needed. Simple calculations can show that w∗i = fA∗(A
∗
i )/fA∗|C∗(A
∗
i | C∗i ), i = 1, . . . , n
satisfies the four conditions below including (1):
E (w∗i ) = 1, E
{
w∗iA
∗
i (C
∗
i )
⊤
}
= 0, E (w∗iA
∗
i ) = 0, and E (w
∗
iC
∗
i ) = 0, i = 1, . . . , n. (3)
Subject to the empirical counterparts of (3), we aim to maximize
∏n
i=1 f(A∗,C∗)(A
∗
i ,C
∗
i ), where
f(A∗,C∗) is the joint density of A
∗ and C∗. Since f(A∗,C∗)(A
∗
i ,C
∗
i ) = {fA∗(A∗i )fC∗(C∗i )}/w∗i , an
equivalent optimization is
min
w∗
n∑
i=1
log(w∗i ), s.t.
n∑
i=1
w∗i = n,
n∑
i=1
w∗iA
∗
i (C
∗
i )
⊤ = 0,
n∑
i=1
w∗iA
∗
i = 0,
n∑
i=1
w∗iC
∗
i = 0, (4)
where w∗ = (w∗1 , . . . , w
∗
n)
⊤. By the method of Lagrangian multipliers, it is easy to show that the
constrained optimization (4) is equivalent to the unconstrained optimization
max
γ
n∑
i=1
log
(
1− γ⊤gi
)
, where gi = ((A
∗
i )
⊤, (C∗i )
⊤, vec(A∗i (C
∗
i )
⊤)⊤)⊤,
with “vec” referring to the vectorization operation, which is unfortunately non-convex.
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To resolve this non-convexity issue, we adopt the regularized approach by Fong et al. (2018)
which allows for an imbalance between A∗i and C
∗
i but meanwhile penalizes such imbalance in the
objective function. Explicitly, we consider an ℓ2-regularized optimization
min
w∗,Γ
[
n∑
i=1
log(w∗i ) +
1
2ρ
{vec(Γ)}⊤{vec(Γ)}
]
, (5)
s.t.
n∑
i=1
w∗i = n,
1
n
n∑
i=1
w∗iA
∗
i (C
∗
i )
⊤ = Γ,
n∑
i=1
w∗iA
∗
i = 0,
n∑
i=1
w∗iC
∗
i = 0,
where ρ > 0 is a tuning parameter. Obviously the constraint n−1
∑n
i=1 w
∗
iA
∗
i (C
∗
i )
⊤ = Γ in (5)
relaxes the sample counterpart of (1), which allows for an imperfect balance between A∗i and C
∗
i .
Meanwhile, such imbalance is regularized via an ℓ2-penalty and a smaller tuning parameter ρ tends
to shrink Γ towards zero.
Note that Γ is a L×p matrix and the optimization (5) is difficult due to its high dimensionality.
To reduce its dimensionality, instead of searching all possible values of Γ, we let Γ = θΓ0 where θ ∈
[−1, 1] is a scalar to be optimized and Γ0 = n−1
∑n
i=1A
∗
i (C
∗
i )
⊤ is the unweighted covariance matrix
between A∗i and C
∗
i . In other words we only consider those weights which can uniformly reduce
the entrywise imbalance between A∗i and C
∗
i to a certain degree. Accordingly the optimization (5)
becomes
min
w∗,−1≤θ≤1
[
n∑
i=1
log(w∗i ) +
θ2
2ρ
{vec(Γ0)}⊤{vec(Γ0)}
]
, (6)
s.t.
n∑
i=1
w∗i = n,
1
n
n∑
i=1
w∗iA
∗
i (C
∗
i )
⊤ = θΓ0,
n∑
i=1
w∗iA
∗
i = 0,
n∑
i=1
w∗iC
∗
i = 0,
By the Lagrangian multiplier and profile method, the optimization (6) can be solved by a double-
loop routine:
Inner Loop : γˆ(θ) = argmax
γ
n∑
i=1
log
{
1− γ⊤hi(θ)
}
, for any fixed θ ∈ [−1, 1];
Outer Loop : θˆ = argmax
−1≤θ≤1
[
n∑
i=1
log
{
1− γˆ(θ)⊤hi(θ)
}
− θ
2
2ρ
{vec(Γ0)}⊤{vec(Γ0)}
]
,
and wˆ∗i =
1
1− γˆ(θˆ)⊤hi(θˆ)
, i = 1, . . . , n,
where hi(θ) = ((A
∗
i )
⊤, (C∗i )
⊤, vec(A∗i (C
∗
i )⊤−nθΓ0)⊤)⊤, i = 1, . . . , n. The inner loop can be solved
by the Broyden–Fletcher–Goldfarb–Shanno algorithm while θˆ in the outer loop can be found by a
grid search.
Remark 2.
1. Both parametric and nonparametric SFPS estimation methods above generalize the methods
by Fong et al. (2018) for continuous treatments since a functional treatment is degenerated into a
continuous treatment if A∗ is one-dimensional, i.e., L = 1.
7
2. As in Remark 1, a large L is preferred to achieve a satisfactory covariate balance, but its prac-
tical selection is constrained by the sample size n and the number of covariates p. The parametric
method involves estimating β and Σ, of which dimensions are p × L and L × L respectively. The
nonparametric method involves balancing the covariance matrix between A∗ and C∗, of which di-
mension is L × p. Therefore both estimations will be computationally difficult if a too large L is
selected.
3. In the nonparametric SFPS estimation, solving (6) involves tuning ρ properly. Generally a
suitable ρ should be small since otherwise a large θˆ is typically obtained, which leads to a liberal
imbalance. However, if ρ is extremely small to indicate a very low tolerance of imbalance between
A∗ and C∗, algorithmic convergence is likely to fail, which also leads to a poor covariate balance.
Following Fong et al. (2018), we set a default value ρ = 0.1/n, but a practitioner may need to
explore multiple values to achieve a satisfactory balance.
3.2 Causal Effect Estimation
To estimate the causal effect of the functional treatment on the scalar outcome, one may fit
a scalar-on-function outcome model via propensity score weighting. The SFPS weight estimates
obtained by either the parametric or nonparametric method in Section 3.1 are used as weights in
the involved objective function such that the bias due to the imbalance between the functional
treatment and covariates can be substantially reduced.
For example, if the outcome model is assumed a functional linear model
E(Y | X) = µ0 +
∫ 1
0
µ(t)X(t) dt, (7)
with the smooth causal effect {µ(t) : t ∈ [0, 1]} and µ0 = E(Y ) since E{X(t)} = 0 for all t ∈ [0, 1],
one may estimate µ is via the following truncation method. Let {ψk(t) : t ∈ [0, 1]; k = 1, . . . , L∗}
be a set of smooth and orthonormal L2 basis functions such that µ(t) ≈ ∑L∗k=1 µkψk(t), t ∈ [0, 1]
where µk =
∫ 1
0 µ(t)ψk(t) dt, k = 1, . . . , L
∗. Then E(Y | X) ≈ µ0 +
∑L∗
k=1 µk{
∫ 1
0 X(t)ψk(t) dt} and
the causal effect can be estimated by µˆ(t) =
∑L∗
k=1 µˆkψk(t), t ∈ [0, 1], where
(µˆ1, . . . , µˆL∗) = argmin
µ1,...,µL∗
n∑
i=1
wˆi
(
Yi − Y¯ −
L∗∑
k=1
µkBik
)2
, (8)
with Y¯ = n−1
∑n
i=1 Yi, Bik =
∫ 1
0 Xi(t)ψk(t) dt, k = 1, . . . , L
∗, i = 1, . . . , n, and wˆi, i = 1, . . . , n
being estimated SFPS weights obtained by either the parametric or nonparametric method in
Section 3.1.
It is very common that the basis functions {ψk : k = 1, . . . , L∗} are chosen as the eigenfunctions
of X and accordingly Bik k = 1, . . . , L
∗, i = 1, . . . , n are FPC scores. Note that the L∗ FPC scores
used to fit the outcome model may be chosen independently and differently from those L FPC
scores used to define FPS for covariate balancing. Different from L of which selection does not
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involve the outcome, the L∗ FPC scores used to fit an outcome model may be selected in terms of
their predictability of the outcome. We will illustrate this numerically in Section 4 below.
4 Simulation
In this section we present a simulation study to evaluate the numerical performance of the
proposed method. We had 200 simulation runs with n = 200 independent subjects in each run. The
noiseless functional treatment for the ith subject was generated by Xi(t) =
∑6
k=1Aikφk(t), t ∈ [0, 1]
where the eigenfunctions are φ2k−1(t) =
√
2sin(2πkt) and φ2k(t) =
√
2cos(2πkt) for k = 1, 2, 3, and
the FPC scores are Ai1 = 4Zi1, Ai2 = 2
√
3Zi2, Ai3 = 2
√
2Zi3, Ai4 = 2Zi4, Ai5 = Zi5, and
Ai6 = Zi6/
√
2, with Zi1, . . . , Zi6 independently sampled from the standard normal distribution.
We considered the following four settings to generate the outcome Yi and a three-dimensional
covariate Ci = (Ci1, Ci2, Ci3)
⊤ depending on whether the FPC scores or outcome are linear in the
covariate.
• Setting 1. The covariate was generated by Ci1 = Zi1 +Wi1, Ci2 = 0.2Zi2 +Wi2, and Ci3 =
0.2Zi3 +Wi3 where Wi1 ∼ N(0, 1), Wi2 ∼ N(0, 0.5) and Wi3 ∼ N(0, 0.5) are independent.
The outcome was obtained by
Yi = 1 +
∫ 1
0
µ(t)Xi(t) dt+ 2Ci1 + ei,
with the true causal effect
µ(t) = 2
√
2sin(2πt) +
√
2cos(2πt) +
√
2sin(4πt)/2 +
√
2cos(4πt)/2, t ∈ [0, 1],
and the noise ei ∼ N(0, 25). In this setting, both the FPC scores (Ai1, . . . , Ai6)⊤ and outcome
Yi are linear in Ci.
• Setting 2. The covariate was generated by Ci1 = (Zi1 + 0.5)2 +Wi1, Ci2 = 0.2Zi2 +Wi2,
and Ci3 = 0.2Zi3 + Wi3 where Wi1 ∼ N(0, 1), Wi2 ∼ N(0, 0.5) and Wi3 ∼ N(0, 0.5) are
independent, so the FPC scores are nonlinear in the covariate. The outcome was generated
the same as in Setting 1.
• Setting 3. The covariate was generated in Setting 1. The outcome was obtained by
Yi = 1 +
∫ 1
0
µ(t)Xi(t) dt+ 2Ci1 +C
2
i2 + ei,
where ei ∼ N(0, 25), so the outcome is nonlinear in the covariate.
• Setting 4. The covariate was generated in Setting 2 while the outcome was generated the
same as in Setting 3, so both the FPC scores and outcome are nonlinear in the covariate.
In each setting, the percentage of variance explained (PVE) was set as PVEL = 0.95 and
0.99 respectively to select L top FPC scores of X to define the rank-L FPS and SFPS. The
corresponding SFPS weights were estimated by both the parametric and nonparametric covariate
balancing methods in Section 3.1 respectively. The quality of imbalance reduction between the FPC
scores and covariate is evaluated by the F-statistic for the linear regression of each selected top FPC
score on the covariate, which was fitted by weighted least squares with the estimated SFPS weights
obtained by the parametric or nonparametric method. The F-statistic for each linear regression
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fitted by ordinary least squares is also given for comparison. The boxplots of these F-statistics are
given in Figures 2, 3, 4, and 5.
All four figures demonstrate a substantial and appealing imbalance reduction between the func-
tional treatment and covariate due to either parametric or nonparametric SFPS weighting for both
PVEL = 0.95 and 0.99. The covariate balancing performances of the parametric and nonparamet-
ric methods are comparably satisfactory except in a few outlying simulation runs. The parametric
method generally outperforms for the top three FPC scores while the nonparametric method is
superior for the other FPC scores.
To estimate the causal effect of the functional treatment, the outcome model (7) was fitted by
the truncation method in (8) where the weights were the estimated SFPS weights obtained by the
parametric or nonparametric method, the basis functions were chosen as the top L∗ eigenfunctions
for X, and L∗ was determined by PVEL∗ = 0.95 and 0.99 respectively. To assess the accuracy
for causal effect estimation, we calculated the integrated squared error (ISE) of each causal effect
estimate in each simulation run and further the averaged ISE (AISE) over all simulation runs,
together with the median ISE (MISE) due to the presence of outlying estimates. To evaluate the
effect of bias removal due to covariate balancing, we computed the integrated squared bias (ISB)
using causal effect estimates of all simulation runs. For comparison, all these summary statistics
were also provided for causal effect estimates without adjustment between the functional treatment
and covariate, each of which was obtained by fitting (8) with all weights being one. These summary
statistics for the four simulation settings are given in Tables 1, 2, 3, and 4 respectively.
Figure 2: Boxplots of F-statistics for linear regression models of selected top FPC scores on the covariate
for Settings 1 and 3. The top FPC scores were selected by PVEL = 0.95. Each linear regression model was
fitted by ordinary least squares (Unweighted) or weighted least squares where weights were the estimated
SFPS weights obtained by either the parametric (Para) or nonparametric (Np) covariate balancing method.
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Figure 3: The same as Figure 2 except for PVEL = 0.99. The boxplots for the sixth FPC score were created
based on 187 simulation runs while those for the other five FPC scores were based on all 200 simulation
runs.
Figure 4: The same as Figure 2 except for Settings 2 and 4.
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Figure 5: The same as Figure 4 except for PVEL = 0.99. The boxplots for the sixth FPC score were created
based on 187 simulation runs while those for the other five FPC scores were based on all 200 simulation
runs.
Table 1: Median ISE (MISE), averaged ISE (AISE), and integrated squared bias (ISB) values of causal effect
estimates for Setting 1. Each causal effect estimate was obtained by fitting the outcome model (7) using the
truncation method in (8) where the weights were all one (Unweighted), the estimated SFPS weights obtained
by either the parametric (Para) or nonparametric (Np) covariate balancing method.
PVEL∗ = 0.95 PVEL∗ = 0.99
MISE AISE ISB MISE AISE ISB
Unweighted 0.3600 0.3767 0.2968 0.6397 0.7591 0.3042
PVEL = 0.95
Para 0.2263 0.2553 0.0508 1.1476 1.6051 0.0772
Np 0.1938 0.2262 0.0539 0.8163 1.1478 0.0684
PVEL = 0.99
Para 0.2159 0.2419 0.0631 0.8002 1.1021 0.0987
Np 0.1943 0.2260 0.0712 0.5937 0.9010 0.0926
As shown in Tables 1, 2, 3, and 4, the ISB values for the causal effect estimators obtained
by each covariate balancing method are always much smaller than those for the unadjusted one,
which demonstrates the effectiveness of the proposed method to reduce the bias in causal effect
estimation.
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Table 2: The same as Table 1 except for Setting 2.
PVEL∗ = 0.95 PVEL∗ = 0.99
MISE AISE ISB MISE AISE ISB
Unweighted 0.3828 0.4143 0.2991 0.7782 0.9333 0.3068
PVEL = 0.95
Para 0.1421 0.1724 0.0055 1.0200 1.4399 0.0258
Np 0.1501 0.1885 0.0059 0.9622 1.4393 0.0122
PVEL = 0.99
Para 0.1252 0.1549 0.0058 0.6571 0.8548 0.0440
Np 0.1444 0.1688 0.0158 0.5878 0.7998 0.0429
The MISE and AISE values in Tables 1, 2, 3, and 4 show that the causal effect estimation accu-
racy is influenced by the choices of PVEL and PVEL∗ . First, for all three causal effect estimators,
using PVEL∗ = 0.95 to select top L
∗ FPC scores in the outcome model always leads to a smaller
MISE/AISE value and thus a better causal effect estimation than setting PVEL∗ = 0.99 regardless
of the choice of PVEL. This is somewhat unsurprising since PVEL∗ = 0.95 selects top L
∗ = 4 FPC
scores of X in the outcome model (7), which is correctly specified as implied by the four simulation
settings above. In this case, the causal effect estimation accuracies of the two covariate balanced
estimators are comparable and substantially better than the unadjusted one. This observation is
consistent with the discussion after (8) in Section 3.2 and highlights the importance of outcome
model specification.
Table 3: The same as Table 1 except for Setting 3.
PVEL∗ = 0.95 PVEL∗ = 0.99
MISE AISE ISB MISE AISE ISB
Unweighted 0.3596 0.3788 0.2982 0.6349 0.7617 0.3055
PVEL = 0.95
Para 0.2269 0.2564 0.0515 1.1306 1.6093 0.0772
Np 0.1931 0.2281 0.0543 0.8099 1.1474 0.0689
PVEL = 0.99
Para 0.2182 0.2437 0.0639 0.7905 1.1004 0.0988
Np 0.2000 0.2277 0.0718 0.5952 0.9004 0.0934
Moreover, for the two adjusted causal effect estimators, selecting top L FPC scores by a larger
PVEL = 0.99 to define SFPS and balance covariates may improve the accuracy for causal effect
estimation compared to PVEL = 0.95. The improvement is substantial if the outcome model is
misspecified, i.e., PVEL∗ = 0.99. When PVEL = PVEL∗ = 0.99, in particular, the two adjusted
causal effect estimators are more accurate than the unadjusted one in almost all settings. This
phenomenon suggests that one use as many FPC scores as possible to define and estimate SFPS
weights for the benefit of both reducing imbalance and enhancing causal effect estimation.
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Table 4: The same as Table 1 except for Setting 4.
PVEL∗ = 0.95 PVEL∗ = 0.99
MISE AISE ISB MISE AISE ISB
Unweighted 0.3844 0.4161 0.3005 0.7789 0.9331 0.3081
PVEL = 0.95
Para 0.1361 0.1754 0.0060 0.9833 1.4363 0.0261
Np 0.1576 0.1903 0.0061 0.9856 1.4399 0.0127
PVEL = 0.99
Para 0.1290 0.1572 0.0064 0.6338 0.8561 0.0436
Np 0.1443 0.1719 0.0161 0.5685 0.8060 0.0437
5 Real Data Application
We applied the proposed parametric and nonparametric covariate balancing methods to the
VAT dataset introduced in Section 1 where we aimed to estimate the causal effect of body shape
on the VAT-to-weight ratio. The dataset consists of 90 female and 60 male subjects. For each
subject, the VAT volume was obtained by a DXA scan and the body circumference sampled at 128
equidistant levels from neck (level 1) to ankle (level 128) was extracted from an optical 3D body
scan. See Lu et al. (2019) for more data collection details. Since VAT is stored near organs in the
abdominal region, we treated the circumference measured from level 30 (below chest) to level 64
(groin) as the functional treatment X, of which domain incorporates the abdominal region. The
multivariate covariate includes ethnicity (white/non-white), the logarithm of height and its square.
We centered all variables before the analysis.
Following the suggestion in Section 4 that one use FPC scores as many as possible to define
SFPS weights, we selected the top L = 4 FPC scoresA = (A1, . . . , AL)
⊤ of the functional treatment
by setting PVEL = 0.99. Their corresponding eigenfunctions are illustrated in Figure 6. Figure
6 shows that the first eigenfunction plays a predominant role in the variation of X with 87.88%
explained by the first FPC score, and that along the first eigenfunction, the variation in the upper
part of the interested body region is larger than that in the lower part.
To assess the quality of the proposed method in improving covariate balance, we calculated
the absolute weighted Pearson correlation between each of the four FPC scores and each covari-
ate where the weight is the estimated SFPS weight obtained by either the parametric (Para) or
nonparametric (Np) method. We also computed the unweighted absolute Pearson correlation for
comparison. The results are illustrated in Figure 7. As shown in Figure 7, both covariate balancing
methods can always reduce the imbalance between the FPC scores and multivariate covariate, and
their improvements for the logarithm of height and its square are particularly substantial. The per-
formances of the two methods are comparably satisfactory, although the parametric one is mostly
slightly better.
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Figure 6: Top four eigenfunctions of the functional treatment and percentages of variation explained by their
corresponding FPC scores.
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Figure 7: Absolute Pearson correlation between each FPC of the functional treatment and each covariate
after weighting by either the parametric (Para) or nonparametric (Np) covariate balancing method. The
unweighted absolute Pearson correlation (Unweighted) is also given for comparison.
To estimate the causal effect of body circumference on the VAT-to-weight ratio, we considered
a functional linear outcome model which includes X, gender (female= 0/male= 1) and their in-
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teraction. To fit the outcome model which involves two unknown coefficient functions for X and
interaction term respectively, we followed the same truncation approach in Section 3.2 where both
coefficient functions are approximated by a finite number of eigenfunctions of X and the functional
linear model is accordingly approximated by a classical linear model on the corresponding FPC
scores, gender and their interactions.
Due to the importance of outcome model specification as indicated in Section 4, we adopted the
association–variation index (AVI) proposed by Su et al. (2017) to select eigenfunctions/FPC scores
of X used in the approximate outcome model. Explicitly the AVI for the kth eigenfunction/FPC
score is defined by Vk = λkβ
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k , where λk = Var(Ak) and βk = Cov(Ak, Y )/Var(Ak), k ≥ 1, which
takes into account both the variation of X each FPC score Ak explains and Ak’s predictability
of the outcome Y . For each k ≥ 1, λk may be estimated by the sample variance of {Aik : i =
1, . . . , n} and βk by may be estimated by the ordinary least square estimate of the slope when
regressing Y on Ak. Following the procedure by Su et al. (2017), we first obtained an initial set of
four eigenfunctions/FPC scores by setting PVE = 0.99 together with their estimated AVI values
Vˆk, k = 1, . . . , 4, and then obtained their sorted AVI values Vˆ(k), k = 1, . . . , 4 in a decreasing order.
Finally we selected the eigenfunction/FPC scores concomitant with the largest three AVI values
such that their cumulative percentage of association–variation explained is at least 0.99, that is,
3 = argminK≤4{
∑K
k=1 Vˆ(k)/
∑4
l=1 Vˆ(l) ≥ 0.99}. The selected eigenfunctions are the first three in
terms of their eigenvalues as illustrated in Figure 6, and their associated FPC scores are used in
the approximate outcome model. The results for fitting the approximate outcome model are given
in Table 5.
Table 5: Coefficient estimates, standard error (SE) and p-values for fitting the approximate outcome model
after weighting by the parametric (Para) and nonparametric (Np) covariate balancing methods respectively.
F-statistics for the overall model significance are also given, together with the corresponding p-values based
on na¨ıve F-tests which ignore the uncertainty in the process of estimating SFPS weights and selecting FPCs.
Para Np
Estimate SE P-value Estimate SE P-value
Intercept 32.94 2.11 < 10−6 32.40 2.23 < 10−6
FPC1 -0.22 0.02 < 10−6 -0.23 0.02 < 10−6
FPC2 -0.36 0.07 1.07× 10−6 -0.41 0.07 < 10−6
FPC3 0.02 0.14 0.8950 0.10 0.14 0.4550
gender -17.28 5.99 0.0045 -17.37 5.54 0.0021
FPC1×gender -0.05 0.04 0.1396 -0.04 0.04 0.2337
FPC2×gender -0.04 0.15 0.7995 0.01 0.14 0.9712
FPC3×gender 0.04 0.27 0.8748 -0.03 0.24 0.8869
F-statistic=33.38, P-value< 10−6 F-statistic=33.62, P-value< 10−6
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Table 5 demonstrates an overall significant causal effect of body circumference on VAT-to-weight
ratio at the level of significance 0.05 no matter if the covariates are balanced by the parametric or
nonparametric method. It also shows that the SFPS weightings by the parametric and nonpara-
metric balancing method lead to almost identical outcome model fitting results.
Figure 8: Estimated causal effects of body circumference on VAT-to-weight ratio for female subjects where
the multivariate covariate is either unadjusted (Unweighted) or adjusted for by the parametric (Para) or
nonparametric (Np) covariate balancing method. The 99% bootstrap pointwise confidence intervals are
given for the two covariate balanced casual effect estimates.
The estimated causal effects of body circumference for females, males and their difference are
illustrated in Figures 8, 9 and 10 respectively, together with their 99% pointwise confidence intervals
based on 10, 000 bootstrap samples. Similar to the observation from Table 5, all three figures show
that the parametric and nonparametric covariate balancing methods lead to very similar causal
effect estimates. They also show that the unadjusted estimates seem to be seriously biased for
the causal effect for females (Figure 8) and the causal effect difference between males and females
(Figure 10), but not for the causal effect for males (Figure 9).
Figure 8 shows that the causal effect of body circumference on VAT-to-weight ratio is overall
significant for females no matter if the covariates are balanced by the parametric or nonparametric
method. This can be validated by p-values < 0.0001 based on na¨ıve F-tests which ignore the
uncertainty in the process of selecting FPCs and estimating SFPS weights. The domain for the
significant causal effect is between levels 36 and 43, which approximately corresponds to the body
region below chest to navel, and the causal effect gradually decreases from level 36 to level 43.
Figure 9 shows that the causal effect of body circumference for males is also overall significant,
with p-values < 0.0001 by na¨ıve F-tests. The significant domain for the causal effect is essentially
the same as that for females, but the causal effect tends to slightly increase from level 36 to level 43.
Despite the seeming different causal effect patterns between females and males, Figure 10 shows
no significant difference in the causal effect of body circumference between the two gender groups,
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with p-values 0.5274 (Para) and 0.6538 (Np) respectively by na¨ıve F-tests.
Figure 9: The same as Figure 8 except for the causal effect for males.
Figure 10: The same as Figure 8 except for the causal effect difference between males and females.
6 Discussion
To the best of our knowledge, this paper is the first to study the causal effect estimation of
functional treatments in observational studies. Due to the lack of a probability density function for
a functional variable in general, we properly define the FPS in terms of a multivariate substitute
for the functional treatment, i.e., its FPC scores. We propose two covariate balancing methods to
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estimate the FPS weights, which are used in an outcome model to estimate the causal effect by
FPS weighting. The appealing numerical performance of the proposed method in both imbalance
reduction and causal effect estimation accuracy is demonstrated by a simulation study. Using
the proposed method, the paper has made the first endeavor to study the causal effect of body
circumference on VAT among all body-shape-based analyses of VAT.
The proposed method may be straightforwardly generalizable to other scenarios. For example,
it is almost directly applicable to handle multidimensional continuous treatments (e.g., Kong et al.,
2019) and functional/categorical outcomes. If the covariate set consists of a functional variable,
the proposed method is also applicable by including its top FPC scores in C (e.g., Miao et al.,
2020). With slight modifications, the proposed method may be used to study the joint causal effect
of multiple functional treatments if the FPS and SFPS are defined in terms of their joint FPC
scores obtained by multivariate functional principal component analysis (e.g., Chiou et al., 2014;
Happ and Greven, 2018).
This paper has a few limitations which are worthy of future studies. First, the proposed method
relies on the FPC scores of the functional treatment. A consistent recovery of them is attainable
if the functional treatment is fully observed or densely measured, but not if it is sparsely and
irregularly measured (e.g., Yao et al., 2005). A future research topic is to develop causal effect
estimation methods for sparsely and irregularly observed functional treatments. Moreover, it is
worthwhile to study the numerical improvements on both parametric and nonparametric methods
for FPS estimation since they may lead to a poor covariate balance if a large number of FPC scores
is selected or the number of covariates is moderate or large. Another interesting research direction
is to study non-truncation methods for outcome model fitting, e.g., via roughness regularization.
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